Synapse - Works

Results (5377)

Pirtobrutinib in heavily pre-treated richter transformation: Updated efficacy and safety results with 18-month median survival follow-up from the phase 1/2 BRUIN study

Meeting Abstract

Wierda, W. G.; Shah, N. N.; Cheah, C. Y.; Lewis, D.; Hoffman, M. S.; Coombs, C. C.; Lamanna, N.; Shuo, M. A.; Jagadeesh, D.; Munir, T.; more...
Oncology Research and Treatment (2024)

Fulltext@MSK | Save

Nivolumab (NIVO) plus chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): 3-year follow-up from CheckMate

Meeting Abstract

Möhler, M.; Janjigian, Y. Y.; Shitara, K.; Garrido, M.; Gallardo, C.; Shen, L.; Yamaguchi, K.; Wyrwicz, L.; Skoczylas, T.; Bragagnoli, A.; more...
Oncology Research and Treatment (2024)

Fulltext@MSK | Save

Four-year overall survival update from the phase 3 HIMALAYA study of tremelimumab (T) plus durvalumab (D) in unresectable hepatocellular carcinoma (uHCC)

Meeting Abstract

Sangro, B.; Chan, S. L.; Kelley, K.; Lau, G.; Kudo, M.; Sukeepaisarnjaroen, W.; De Toni, E.; Furuse, J.; Kang, Y. K.; Galle, P. R.; more...
Oncology Research and Treatment (2024)

Fulltext@MSK | Save

Outcomes by baseline liver function in patients with unresectable hepatocellular carcinoma treated with tremelimumab and durvalumab in the phase 3 HIMALAYA study

Meeting Abstract

Vogel, A.; Chan, S. L.; Furuse, J.; Tak, W. Y.; Masi, G.; Varela, M.; Kim, J. H.; Tanasanvimon, S.; Reig, M.; Dayyani, F.; more...
Oncology Research and Treatment (2024)

Fulltext@MSK | Save

Impact of viral aetiology in the Phase 3 HIMALAYA study of tremelimumab (T) plus durvalumab (D) in unresectable hepatocellular carcinoma (uHCC)

Meeting Abstract

Chan, S. L.; Kudo, M.; Sangro, B.; Kelley, K.; Furuse, J.; Park, J. W.; Sunpaweravong, P.; Fasolo, A.; Yau, T.; Kawaoka, T.; more...
Oncology Research and Treatment (2024)

Fulltext@MSK | Save

Phase 3 study of tucatinib, trastuzumab, and modified FOLFOX6 as first-line treatment in HER2+ metastatic colorectal cancer (MOUNTAINEER-03, trial in progress)

Meeting Abstract

Heinemann, V.; André, T.; Bekaii-Saab, T.; Cercek, A.; Nakamura, Y.; Raghav, K.; Siena, S.; Strickler, J.; Van Cutsem, E.; Adelberg, D.; more...
Oncology Research and Treatment (2024)

Fulltext@MSK | Save

Phase II, single-arm, open-label study of dostarlimab monotherapy in previously untreated patients with stage II/III dMMR/MSI-H locally advanced rectal cancer: Trial in progress

Meeting Abstract

Cercek, A.; Bachet, J. B.; Capdevilla, J.; Starling, N.; Chen, E.; Di Bartolomeo, M.; Yoshino, T.; Vlahovic, G.; Zografos, E.; O'donnell, S.; more...
Oncology Research and Treatment (2024)

Fulltext@MSK | Save

Final analysis of patients with metastatic castration-resistant prostate cancer and homologous recombination repair gene alterations receiving first-line niraparib with abiraterone acetate plus prednisone (MAGNITUDE Study) for cancer caregivers: A pilot to address existential distress in caregivers of hematopoietic stem cell transplant patients

Meeting Abstract

Olivier, K.; Smith, M.; Rathkopf, D. E.; Small, E.; Guckert, M.; Chi, K. N.
Oncology Nursing Forum (2024)

Fulltext@MSK | Save

Patient-reported outcomes in patients with metastatic castration-resistant prostate cancer and BRCA1/2 mutations receiving first-line niraparib with abiraterone acetate plus prednisone (Magnitude study)

Meeting Abstract

Nguyen, C.; Rathkopf, D. E.; Chi, K. N.; Small, E.; Smith, M.
Oncology Nursing Forum (2024)

Fulltext@MSK | Save

Nurse-led meaning-centered psychotherapy for cancer caregivers: A pilot to address existential distress in caregivers of hematopoietic stem cell transplant patients

Meeting Abstract

McAndrew, N.; Wallace, L.; Guttormson, J.; McCracken, C.; Ferrell, B.; Applebaum, A.
Oncology Nursing Forum (2024)

Fulltext@MSK | Save